Myriad Genetics
MYGN
#6655
Rank
A$1.03 B
Marketcap
A$11.06
Share price
3.96%
Change (1 day)
-52.14%
Change (1 year)

Myriad Genetics (MYGN) - Total assets

Total assets on the balance sheet as of September 2025 : A$1.09 Billion

According to Myriad Genetics's latest financial reports the company's total assets are A$1.09 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Myriad Genetics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$1.65 B-1.83%
2023-12-31A$1.68 B-4.47%
2022-12-31A$1.76 B-3.31%
2021-12-31A$1.82 B
2020-06-30A$2.03 B-8.54%
2019-06-30A$2.22 B40.15%
2018-06-30A$1.58 B0.83%
2017-06-30A$1.57 B33.2%
2016-06-30A$1.18 B18.7%
2015-06-30A$0.99 B13.99%
2014-06-30A$0.87 B-0.78%
2013-06-30A$0.88 B30.58%
2012-06-30A$0.67 B18.32%
2011-06-30A$0.56 B-18.71%
2010-06-30A$0.70 B21.61%
2009-06-30A$0.57 B10.42%
2008-06-30A$0.52 B17.72%
2007-06-30A$0.44 B18.6%
2006-06-30A$0.37 B79.51%
2005-06-30A$0.20 B-23.62%
2004-06-30A$0.27 B-0.37%
2003-06-30A$0.27 B-2.36%
2002-06-30A$0.28 B-16.65%
2001-06-30A$0.33 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Bio-Rad Laboratories
BIO
A$14.59 B 1,231.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
A$8.87 B 710.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A$33.26 M-96.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$11.45 B 945.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$126.68 B 11,461.74%๐Ÿ‡บ๐Ÿ‡ธ USA